Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Sigyn Therapeutics ( (SIGY) ) has provided an update.
On January 11, 2025, Sigyn Therapeutics appointed Michael Ryan to their Board of Directors. Mr. Ryan brings extensive experience in the early-stage technology and life science industry, having co-founded Irrus Investments, Ireland’s largest angel investment syndicate focusing on life science companies. This strategic appointment underscores Sigyn Therapeutics’ commitment to enhancing its leadership team with experienced professionals, potentially strengthening its market position and future growth prospects.
More about Sigyn Therapeutics
YTD Price Performance: 21.43%
Average Trading Volume: 252
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $5.06M
For detailed information about SIGY stock, go to TipRanks’ Stock Analysis page.